A detailed history of Two Sigma Investments, LP transactions in Pulmonx Corp stock. As of the latest transaction made, Two Sigma Investments, LP holds 27,441 shares of LUNG stock, worth $173,975. This represents 0.0% of its overall portfolio holdings.

Number of Shares
27,441
Previous 64,489 57.45%
Holding current value
$173,975
Previous $408,000 44.36%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$5.59 - $8.58 $207,098 - $317,871
-37,048 Reduced 57.45%
27,441 $227,000
Q2 2024

Aug 14, 2024

SELL
$5.77 - $9.82 $154,324 - $262,645
-26,746 Reduced 29.32%
64,489 $408,000
Q1 2024

May 15, 2024

SELL
$8.71 - $14.65 $676,810 - $1.14 Million
-77,705 Reduced 46.0%
91,235 $845,000
Q4 2023

Feb 14, 2024

SELL
$7.89 - $13.14 $60,366 - $100,534
-7,651 Reduced 4.33%
168,940 $2.15 Million
Q3 2023

Nov 14, 2023

SELL
$9.88 - $14.0 $830,364 - $1.18 Million
-84,045 Reduced 32.25%
176,591 $1.82 Million
Q2 2023

Aug 14, 2023

SELL
$10.78 - $13.65 $481,165 - $609,267
-44,635 Reduced 14.62%
260,636 $3.42 Million
Q1 2023

May 15, 2023

BUY
$7.49 - $12.54 $1.29 Million - $2.16 Million
172,493 Added 129.91%
305,271 $3.41 Million
Q4 2022

Feb 14, 2023

BUY
$4.92 - $17.35 $255,977 - $902,685
52,028 Added 64.43%
132,778 $1.12 Million
Q3 2022

Nov 14, 2022

SELL
$15.35 - $23.99 $948,031 - $1.48 Million
-61,761 Reduced 43.34%
80,750 $1.35 Million
Q2 2022

Aug 15, 2022

BUY
$14.0 - $27.95 $1.59 Million - $3.18 Million
113,676 Added 394.23%
142,511 $2.1 Million
Q1 2022

May 16, 2022

BUY
$21.13 - $35.65 $609,283 - $1.03 Million
28,835 New
28,835 $715,000
Q4 2021

Feb 14, 2022

SELL
$29.72 - $45.1 $4.2 Million - $6.38 Million
-141,372 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$35.98 - $44.48 $4.5 Million - $5.56 Million
124,972 Added 762.02%
141,372 $5.09 Million
Q2 2021

Aug 16, 2021

BUY
$37.61 - $48.0 $616,804 - $787,200
16,400 New
16,400 $724,000

Others Institutions Holding LUNG

About Pulmonx Corp


  • Ticker LUNG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,268,400
  • Market Cap $236M
  • Description
  • Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...
More about LUNG
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.